SAMSUNG PHARMACEUTICAL.CO.,Ltd. Logo

SAMSUNG PHARMACEUTICAL.CO.,Ltd.

001360 | KO

Overview

Corporate Details

ISIN(s):
KR7001360007
LEI:
Country:
South Korea
Address:
경기도 화성시 향남읍 제약공단4길 10 -, 화성시
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

No description available.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-25 00:00
Regulatory Filings
[기재정정]단일판매ㆍ공급계약체결
Korean 12.2 KB
2025-08-22 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(약식)
Korean 63.8 KB
2025-08-21 00:00
Share Issue/Capital Change
유상증자또는주식관련사채등의발행결과(자율공시)
Korean 5.8 KB
2025-08-20 00:00
Share Issue/Capital Change
[기재정정]주요사항보고서(전환사채권발행결정)
Korean 134.9 KB
2025-08-14 00:00
Annual Report
[기재정정]사업보고서 (2024.12)
Korean 1.1 MB
2025-08-14 00:00
Interim / Quarterly Report
반기보고서 (2025.06)
Korean 916.3 KB
2025-08-08 00:00
Capital/Financing Update
주요사항보고서(전환사채권발행결정)
Korean 67.1 KB
2025-05-15 00:00
Quarterly Report
분기보고서 (2025.03)
Korean 896.6 KB
2025-03-27 00:00
AGM Information
정기주주총회결과 (제 71기)
Korean 22.5 KB
2025-03-19 00:00
Audit Report / Information
감사보고서제출
Korean 11.9 KB
2025-03-19 00:00
Audit Report / Information
사업보고서 (2024.12)
Korean 495.1 KB
2025-03-12 00:00
Pre-Annual General Meeting Information
주주총회소집결의
Korean 9.2 KB
2025-03-12 00:00
Pre-Annual General Meeting Information
주주총회소집공고
Korean 120.2 KB
2025-03-12 00:00
Proxy Solicitation & Information Statement
의결권대리행사권유참고서류
Korean 83.1 KB
2025-03-12 00:00
Pre-Annual General Meeting Information
주주총회집중일개최사유신고
Korean 5.4 KB

Automate Your Workflow. Get a real-time feed of all SAMSUNG PHARMACEUTICAL.CO.,Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for SAMSUNG PHARMACEUTICAL.CO.,Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for SAMSUNG PHARMACEUTICAL.CO.,Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

REGENXBIO Inc. Logo
Developing AAV gene therapies for retinal, metabolic, and neurodegenerative diseases.
United States of America
RGNX
Rein Therapeutics, Inc. Logo
Clinical-stage biopharma developing novel therapies for orphan pulmonary diseases and fibrosis.
United States of America
RNTX
Rekah Pharmaceutical Prod Ltd. Logo
A full-service generic pharma manufacturer of drugs, devices, and supplements for global markets.
Israel
REKA
Relay Therapeutics, Inc. Logo
Developing precision medicines for oncology & genetic diseases by analyzing protein motion.
United States of America
RLAY
RELIEF Therapeutics Holding AG Logo
Developing and commercializing novel therapies for rare and ultra-rare diseases.
Switzerland
RLF
Renascience Inc. Logo
Develops innovative drugs and AI-powered medical devices for aging and hereditary diseases.
Japan
4889
Replek AD Logo
Manufactures & distributes generic medicines, supplements, and cosmetic products to over 25 countries.
North Macedonia
REPL
REVVITY, INC. Logo
Provides life sciences & diagnostics technologies to support workflows from discovery to cure.
United States of America
RVTY
REYON PHARMACEUTICAL CO., LTD Logo
Develops & makes APIs, generics, cell/gene therapies, and offers biopharma CDMO services.
South Korea
102460
Rezolute, Inc. Logo
Developing therapies for rare metabolic diseases, focusing on hyperinsulinism-caused hypoglycemia.
United States of America
RZLT

Talk to a Data Expert

Have a question? We'll get back to you promptly.